1Blanco-Collo LM,Martin-Ventura JL,Vivanco F,et al.Biology of atherosclerotic plaques:what we are learning from proteomics analysis[J].Cardiovasc Res,2006,72 (1):18-29.
8Arrell Dk,Au BPY,Fraser H,et al.Pharmacoloyical preconditioning mediates altered phosphorylation of the "unphosphorylatable" myosin light chain[J].Circulation,2000,102(suppl Ⅱ):Ⅱ -202.
9De Celle T,Vanrobaeys F,Lijnen P,et al.Alterations in mouse cardiac proteome after in vivo myocardial infarction:permanent ischaemia versus ischaemia-reperfusion[J].Exp Physiol,2005,90(4):593-606.
10Jin X,Xia L,Wang LS,et al.Differential protein expression in hypertrophic heart with and without hypertension in spontaneously hypertensive rats[J].Proteomics,2006,6 (6):1948 -1956.
1Williams KL, Gooley AA, Haynes PA, et al. Analy- tical biotechnology: applications for downstream processing[ J ]. Aust J Biotechnol, 1991, 5 (2) :96- 100.
2Reddy KS, Perrotta PL. Proteomics in transfusion medicine [ J ]. Transfusion, 2004, 44 (4) :601-604.
3Brigulla M, Thiele T, Scharf C, et al. Proteomics as a tool for assessment of therapeutics in transfusion medicine: evaluation of prothrombin complex con- centrates [ J ]. Transfusion, 2006, 46 ( 3 ) : 377-385.
4Clifton JG, Huang F, Kovac S, et al. Proteomic characterization of plasma-derived clotting factor VI-- von Willebrand factor concentrates [ J ]. Electro- phoresis, 2009, 30(20) :3636-3646.
5C.lifton J, Huang F, Gaso-Sokac D, et al. Use of proteomics for validation of the isolation process of clotting factor IX from human plasma [ J ]. J Pro- teomics, 2010, 73(3) :678-688.
6Steil L, Thiele T, Hammer E, et al. Proteomic characterization of freeze-dried human plasma : providing treatment of bleeding disorders without the need for a cold chain [ J ]. Transfusion, 2008, 48 ( 11 ) :2356-2363.
7Sidhu RS, Le T, Brimhall B, et al. Study of coagula- tion factor activities in apheresed thawed fresh frozen plasma at 1-6 degrees C for five days [ J ]. J Clin Apher, 2006, 21(4):224-226.
8Yazer MH, Cortese-Hassett A, Triulzi DJ. Coagula- tion factor levels in plasma frozen within 24 hours of phlebotomy over 5 days of storage at 1 to 6 degrees C [J]. Transfusion, 2008, 48(12) :2525-2530.
9Von Heymann C, Keller MK, Spies C, et al. Activity of clotting factors in fresh-frozen plasma during storage at 4 degrees C over 6 days [ J ]. Transfusion, 2009, 49 (5) : 913-920.
10Crettaz D, Sensebe L, Vu DH, et al. Proteomics of methylene blue photo-treated plasma before and afterremoval of the dye by an absorbent filter [ J ]. Proteomics, 2004, 4 (3) : 881-891.
